Tomohisa Nagoshi
Overview
Explore the profile of Tomohisa Nagoshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
1005
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Aizawa T, Inoue Y, Ito S, Morimoto S, Ogawa K, Nagoshi T, et al.
Heart Vessels
. 2023 Jun;
38(10):1218-1227.
PMID: 37318650
Several studies have investigated the association between P2Y12 reaction unit (PRU) value and major adverse cardiovascular events (MACEs) in patients with ischemic heart disease, but there is no well-established consensus...
12.
Kashiwagi Y, Nagoshi T, Kimura H, Tanaka Y, Oi Y, Inoue Y, et al.
ESC Heart Fail
. 2023 Mar;
10(3):1860-1870.
PMID: 36942494
Aims: Although the haemodynamic effects of angiotensin receptor-neprilysin inhibitor (ARNI) on patients with heart failure have been demonstrated, the effect on glucose metabolism has not been fully elucidated. We retrospectively...
13.
Ogawa T, Inoue Y, Aizawa T, Morimoto S, Ogawa K, Nagoshi T, et al.
Cardiovasc Interv Ther
. 2023 Feb;
38(3):309-315.
PMID: 36800064
The small-balloon technique used to retrieve a dislodged coronary stent is less studied. We investigated the small-balloon technique to study the capture force and retrieval rate of dislodged proximal or...
14.
Narui R, Yamashita S, Yoshitake M, Nagoshi T, Kunihara T, Yoshimura M, et al.
J Cardiol Cases
. 2023 Jan;
27(1):16-18.
PMID: 36618840
Learning Objective: Some cases requiring iatrogenic atrial septal defect (IASD) closure after atrial fibrillation (AF) ablation have been reported. We describe the case of an arrhythmogenic right ventricular cardiomyopathy patient...
15.
Shirasaki K, Minai K, Kawai M, Tanaka T, Ogawa K, Inoue Y, et al.
Medicine (Baltimore)
. 2023 Jan;
101(52):e32439.
PMID: 36595999
In the pathophysiology of acute coronary syndrome (ACS), platelet (PLT) and neutrophil (Neu) crosstalk may be important for activating coagulation and inflammation. It has been speculated that PLTs and Neu...
16.
Oh T, Ogawa K, Nagoshi T, Minai K, Ogawa T, Kawai M, et al.
ESC Heart Fail
. 2022 Dec;
10(2):955-964.
PMID: 36478404
Aims: Pulmonary congestion, reduced cardiac output, neurohumoral factor activation, and decreased renal function associated with decreased cardiac function may have various effects on haemograms. The relationship between these factors and...
17.
Oi Y, Nagoshi T, Kimura H, Tanaka Y, Yoshii A, Yasutake R, et al.
Int J Mol Sci
. 2022 Aug;
23(15).
PMID: 35955507
Increasing evidence suggests natriuretic peptides (NPs) coordinate interorgan metabolic crosstalk. We recently reported exogenous ANP treatment ameliorated systemic insulin resistance by inducing adipose tissue browning and attenuating hepatic steatosis in...
18.
Takahashi H, Nagoshi T, Kimura H, Tanaka Y, Yasutake R, Oi Y, et al.
Sci Rep
. 2022 Jul;
12(1):12740.
PMID: 35882940
There is growing interest in 3-iodothyronamine (T1AM), an active thyroid hormone metabolite, that induces negative inotropic and chronotropic actions in the heart and exerts systemic hypothermic action. We explored the...
19.
Ogawa T, Yamashita S, Oseto H, Yokoyama M, Itakura R, Kang R, et al.
Circ J
. 2022 Jul;
86(8):1229-1236.
PMID: 35786690
Background: Pulmonary vein (PV) stenosis after atrial fibrillation (AF) ablation is rare; however, it remains a serious complication. PV angioplasty is reportedly an effective therapy; however, a dedicated device for...
20.
Kashiwagi Y, Nagoshi T, Ogawa K, Kawai M, Yoshimura M
Cureus
. 2022 Apr;
14(3):e22762.
PMID: 35371876
A recent study suggested that angiotensin receptor/neprilysin inhibitor (ARNI; sacubitril/valsartan) can improve functional capacity and cardiac reverse remodeling in patients with heart failure with reduced ejection fraction (HFrEF). Another study...